Rein Therapeutics, Inc. (RNTX) › Total AssetsRein Therapeutics, Inc. (RNTX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2016: $22.02M2017: $52.69M2018: $30.31M2019: $26.47M2020: $16.34M2021: $48.48M2022: $22.01M2023: $106.01M2024: $62.19M2025: $24.16M$24.16M2016Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$24.16M-61.2%2024$62.19M-41.3%2023$106.01M+381.7%2022$22.01M-54.6%2021$48.48M+196.7%2020$16.34M-38.3%2019$26.47M-12.7%2018$30.31M-42.5%2017$52.69M+139.3%2016$22.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share